{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:36:44Z","timestamp":1725583004321},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Jiangxi Provincial Health Commission science and technology plan","award":["No.202310152"],"award-info":[{"award-number":["No.202310152"]}]},{"name":"the Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["No.2022B563"],"award-info":[{"award-number":["No.2022B563"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03798-7","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:05:29Z","timestamp":1725523529000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary neurolymphomatosis with MAG antibody: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Honglian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Bei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"3798_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/bloodadvances.2020003666","volume":"5","author":"A Khurana","year":"2021","unstructured":"Khurana A, Novo M, Nowakowski GS, Ristow KM, Spinner RJ, Hunt CH, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the Rituximab era. Blood Adv. 2021;5:1379\u201387.","journal-title":"Blood Adv"},{"key":"3798_CR2","first-page":"212","volume":"12","author":"HK Gan","year":"2010","unstructured":"Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neurooncology. 2010;12:212\u20135.","journal-title":"Neurooncology"},{"key":"3798_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2015.06.003","volume":"355","author":"JP St\u00fcbgen","year":"2015","unstructured":"St\u00fcbgen JP. Lymphoma-associated dysimmune polyneuropathies. J Neurol Sci. 2015;355:25\u201336.","journal-title":"J Neurol Sci"},{"key":"3798_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/PPO.0b013e31826c5ad5","volume":"18","author":"JM Baehring","year":"2012","unstructured":"Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J (Sudbury Mass). 2012;18:463\u20138.","journal-title":"Cancer J (Sudbury Mass)"},{"key":"3798_CR5","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","volume":"115","author":"S Grisariu","year":"2010","unstructured":"Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115:5005\u201311.","journal-title":"Blood"},{"key":"3798_CR6","first-page":"104","volume":"5","author":"JM Baehring","year":"2003","unstructured":"Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH, Neurolymphomatosis. Neurooncology. 2003;5:104\u201315.","journal-title":"Neurooncology"},{"key":"3798_CR7","doi-asserted-by":"crossref","unstructured":"Vecchio D, Mittino D, Terazzi E, Nassi L, Conconi A, Monaco F. A case of cranial multinevritis: from the onset to the diagnosis of primary neurolymphomatosis. BMJ case Rep 2012: 2012.","DOI":"10.1136\/bcr.06.2011.4299"},{"key":"3798_CR8","doi-asserted-by":"crossref","unstructured":"Steck AJ. Anti-MAG neuropathy: from biology to clinical management. J Neuroimmunol 2021: 361: 577725.","DOI":"10.1016\/j.jneuroim.2021.577725"},{"key":"3798_CR9","doi-asserted-by":"crossref","unstructured":"Kinter J, Lazzati T, Schmid D, Zeis T, Erne B, L\u00fctzelschwab R et al. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-tooth 1A disease. Neurobiol Dis 2013: 49: 221\u201331.","DOI":"10.1016\/j.nbd.2012.08.009"},{"key":"3798_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jns.2004.10.005","volume":"228","author":"RH Quarles","year":"2005","unstructured":"Quarles RH. Comparison of CNS and PNS myelin proteins in the pathology of myelin disorders. J Neurol Sci. 2005;228:187\u20139.","journal-title":"J Neurol Sci"},{"key":"3798_CR11","doi-asserted-by":"crossref","unstructured":"Gabriel JM, Erne B, Miescher GC, Miller SL, Vital A, Vital C et al. Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy, brain: a journal of neurology 1996: 119 (Pt 3): 775\u201387.","DOI":"10.1093\/brain\/119.3.775"},{"key":"3798_CR12","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1038\/s41598-019-42545-8","volume":"9","author":"E Pascual-Go\u00f1i","year":"2019","unstructured":"Pascual-Go\u00f1i E, Mart\u00edn-Aguilar L, Lleix\u00e0 C, Mart\u00ednez-Mart\u00ednez L, Sim\u00f3n-Talero MJ, D\u00edaz-Manera J, et al. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy. Sci Rep. 2019;9:6155.","journal-title":"Sci Rep"},{"key":"3798_CR13","doi-asserted-by":"publisher","first-page":"Itc177","DOI":"10.7326\/AITC202212200","volume":"175","author":"W. I Gonsalves","year":"2022","unstructured":"Gonsalves W. I. S. V. Rajkumar 2022 Monoclonal gammopathy of undetermined significance. Ann Intern Med 175 Itc177\u201392.","journal-title":"Ann Intern Med"},{"key":"3798_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/hon.2685","volume":"37","author":"SG Papageorgiou","year":"2019","unstructured":"Papageorgiou SG, Thomopoulos TP, Spathis A, Bouchla A, Glezou I, Stavroulaki G, et al. Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma. Hematol Oncol. 2019;37:634\u20137.","journal-title":"Hematol Oncol"},{"key":"3798_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ana.410260408","volume":"26","author":"E Nobile-Orazio","year":"1989","unstructured":"Nobile-Orazio E, Francomano E, Daverio R, Barbieri S, Marmiroli P, Manfredini E, et al. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. Ann Neurol. 1989;26:543\u201350.","journal-title":"Ann Neurol"},{"key":"3798_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3988\/jcn.2015.11.3.283","volume":"11","author":"JP St\u00fcbgen","year":"2015","unstructured":"St\u00fcbgen JP. Autoantibody-mediated sensory Polyneuropathy Associated with Indolent B-Cell Non-hodgkin\u2019s lymphoma: a report of two cases. J Clin Neurol (Seoul Korea). 2015;11:283\u20136.","journal-title":"J Clin Neurol (Seoul Korea)"},{"key":"3798_CR17","doi-asserted-by":"publisher","first-page":"e15049","DOI":"10.1097\/MD.0000000000015049","volume":"98","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Ju W, Luo S, Yang Y. Diffuse large B-cell lymphoma involving peripheral nervous system with IgM antibodies against GM1 and GD1b: a case report. Medicine. 2019;98:e15049.","journal-title":"Medicine"},{"key":"3798_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neures.2014.09.010","volume":"91","author":"Y Hamada","year":"2015","unstructured":"Hamada Y, Hirano M, Kuwahara M, Samukawa M, Takada K, Morise J, et al. Binding specificity of anti-HNK-1 IgM M-protein in anti-MAG neuropathy: possible clinical relevance. Neurosci Res. 2015;91:63\u20138.","journal-title":"Neurosci Res"},{"key":"3798_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000111565","volume":"16","author":"T Ariga","year":"2008","unstructured":"Ariga T, Suetake K, Nakane M, Kubota M, Usuki S, Kawashima I, et al. Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors. Neuro-Signals. 2008;16:226\u201334.","journal-title":"Neuro-Signals"},{"key":"3798_CR20","doi-asserted-by":"crossref","unstructured":"Morise J, Takematsu H, Oka S. The role of human natural killer-1 (HNK-1) carbohydrate in neuronal plasticity and disease, Biochimica et biophysica acta General subjects 2017: 1861: 2455\u201361.","DOI":"10.1016\/j.bbagen.2017.06.025"},{"key":"3798_CR21","doi-asserted-by":"crossref","unstructured":"Mat\u00e0 S, Ambrosini S, Mello T, Lolli F, Minciacchi D. Anti-myelin associated glycoprotein antibodies recognize HNK-1 epitope on CNS. J Neuroimmunol 2011: 236: 99\u2013105.","DOI":"10.1016\/j.jneuroim.2011.05.002"},{"key":"3798_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ana.410240118","volume":"24","author":"E Nobile-Orazio","year":"1988","unstructured":"Nobile-Orazio E, Baldini L, Barbieri S, Marmiroli P, Spagnol G, Francomano E, et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol. 1988;24:93\u20137.","journal-title":"Ann Neurol"},{"key":"3798_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ana.410360313","volume":"36","author":"E Nobile-Orazio","year":"1994","unstructured":"Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol. 1994;36:416\u201324.","journal-title":"Ann Neurol"},{"key":"3798_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","volume":"31","author":"B Engelhardt","year":"2009","unstructured":"Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31:497\u2013511.","journal-title":"Semin Immunopathol"},{"key":"3798_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nurt.2009.04.013","volume":"6","author":"AP Algazi","year":"2009","unstructured":"Algazi AP, Kadoch C, Rubenstein JL. Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics: J Am Soc Experimental Neurother. 2009;6:587\u201397.","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03798-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03798-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03798-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:08:41Z","timestamp":1725523721000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03798-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3798"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03798-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was signed by the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was signed by the patient\u2019s daughter.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors report no disclosures relevant to the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"320"}}